drugset / Trial / NCT05129748

Efficacy of Sodium Thiosulfate and Mannitol in Reducing Ototoxicity in Adult Patients Receiving Cisplatin Chemotherapy

NCT05129748

Phase 2 Recruiting 92 enrolled Sunnybrook Health Sciences Centre
RandomizedParallel-groupSingle-blindPrevention

Summary

One common side effect of cisplatin chemotherapy is ototoxicity. The drugs sodium thiosulfate and mannitol may protect against cisplatin-induced hearing loss. Specifically, sodium thiosulfate has been found to protect the cells in the inner ear, and may therefore prevent hearing loss. Mannitol can help sodium thiosulfate enter the inner ear, and ponteially increase the effectiveness of sodium thiosulfate. This study aims to assess the efficacy of sodium thiosulfate and mannitol to reduce the hearing impairment caused by cisplatin chemotherapy.

Timeline

Start
2023-02-15
Primary completion
2027-01
Completion
2027-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Mannitol Diagnostic / imaging agent Intravenous
Subject Sodium Thiosulfate Diagnostic / imaging agent Intravenous